CRMD vs TECH · P/E 3.9, rev $43.5M vs P/E 65, rev $1.22B
CorMedix Inc (CRMD) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
CorMedix Inc (CRMD) is a biotechnology company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported CRMD revenue for 2024-12-31 was $43.5M. Net income was -$17.9M. Revenue was up 66363.1% from 2022-12-31 to 2024-12-31. CRMD currently screens at market cap $655.9M and trailing P/E 3.9.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
CRMD currently screens at market cap $655.9M and trailing P/E 3.9. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the CRMD and TECH stock pages for the full models.
Not investment advice.